©2025 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Eyewire News: The Podcast
Eyewire Podcast Logo Outlined
Eyewire News: The Podcast

07.23.25

Harrow Adds Biosimilars to US Portfolio

Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

09.17.25

Breaking News From the ESCRS Congress in Copenhagen

09.10.25

Vision Advocacy Leaders Speak Out Against Proposed NEI Cuts

09.03.25

Update on Investigational Treatments for Retinal Diseases

08.27.25

CE Certification for New Glaucoma Surgical Implant

08.20.25

Special Report: TFOS DEWS III Leaders Discuss New DED Guidance

08.13.25

First Commerical Surgeries Performed with MacTel Therapy

08.06.25

Alcon Acquires Staar for $1.5 Billion

07.30.25

Tryptyr Now Available in US

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D
close-x